NTRK1 and breast carcinoma: We, along with others, have reported that the receptor tyrosine kinase RET plays an important role in endocrine therapies resistance in ER+ breast cancer cells by promoting ER phosphorylation, cell proliferation, and cell survival [4, 11, 12, 16].